Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy
While both local vasoconstrictors and tourniquet application are recognized methods for blood loss control, there is a paucity of head-to-head randomized controlled trials directly comparing these two distinct approaches in laparoscopic myomectomy. Existing data often compare these methods to no intervention or to other less common techniques. A direct comparison is essential to determine which method offers superior hemostasis with an acceptable safety profile in the laparoscopic setting. This study aims to address this gap in the literature.
• Female patients aged 18-45 years.
• Diagnosed with symptomatic uterine leiomyomas requiring laparoscopic myomectomy.
• Presence of at least one myoma with a diameter ≥3 cm and ≤10 cm.
• Patients with up to 3 myomas (to standardize surgical complexity).
• Preoperative hemoglobin level ≥10 g/dL.
• Ability to provide informed consent.